U
Genesis Healthcare, Inc. GENN
$0.0002 $0.000.00%
Recommendation
--
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
D
Sell 3/17/2021Upgraded
Genesis Healthcare, Inc. (GEN) was upgraded to D from D- on 3/17/2021 due to a substantial increase in the efficiency index, growth index and total return index. Operating cash flow increased 158.17% from -$59.44M to $34.57M, net income increased 87.78% from -$62.79M to -$7.67M, and earnings per share increased from -$0.555 to -$0.0693.
D
Sell 11/12/2020Downgrade
Genesis Healthcare, Inc. (GEN) was downgraded to D- from D on 11/12/2020 due to a significant decline in the solvency index, efficiency index and total return index. Net income declined 185.36% from -$22.01M to -$62.79M, and total capital declined 6.26% from $2.96B to $2.77B.
D
Sell 3/11/2020Downgrade
Genesis Healthcare, Inc. (GEN) was downgraded to D from D+ on 3/11/2020 due to a decline in the total return index.
D
Sell 1/21/2020Upgraded
Genesis Healthcare, Inc. (GEN) was upgraded to D+ from D on 1/21/2020 due to a significant increase in the total return index and volatility index.
D
Sell 10/20/2017Downgrade
Genesis Healthcare, Inc. (GEN) was downgraded to D from C- on 10/20/2017 due to a significant decline in the volatility index, total return index and growth index. Operating cash flow declined 45.11% from $44.63M to $24.5M, EBIT declined 42.96% from $53.26M to $30.38M, and earnings per share declined from -$0.5525 to -$0.6986.
C
Hold 5/16/2014Upgraded
Skilled Healthcare Group, Inc. (SKH) was upgraded to C- from D+ on 5/16/2014 due to an increase in the volatility index, growth index and total return index. EBIT increased 15.79% from $9M to $10.42M.
Weiss Ratings